<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03024268</url>
  </required_header>
  <id_info>
    <org_study_id>MITHRAS</org_study_id>
    <nct_id>NCT03024268</nct_id>
  </id_info>
  <brief_title>MitraClip® and Hemodynamic Effects of Relevant Iatrogenic Atrial Septum Defect Closure</brief_title>
  <official_title>MitraClip® and Hemodynamic Effects of Relevant Iatrogenic Atrial Septum Defect Closure - Evaluation of Morphologic and Functional Changes in a Randomized Setting</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Leipzig</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Leipzig</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim of this prospective trial is to assess the hemodynamic effects of a MitraClip procedure
      caused iatrogenic arterial septal defect (iASD) and the functional changes after
      interventional iASD closure in a randomized setting.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Transcatheter mitral valve repair with the MitraClip system is a therapeutic alternative to
      surgery in selected high-risk patients. Clip placement requires interatrial transseptal
      puncture and meticulous manipulation of the steerable sheath. There is evidence that the
      persistence of a relevant iASD after MitraClip is associated with worse clinical outcomes and
      increased mortality.

      The purpose of this study is to investigate, if the interventional closure of an persistant
      hemodynamic relevant iASD 30 days after MitraClip implantation, has favorable effects on
      clinical outcome. Eligible patients, after obtaining written informed consent, are 1:1
      randomized either in group A (interventional occlusion of iASD) or group B (best supportive
      care).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">July 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Exercise tolerance: 6 minute walking test</measure>
    <time_frame>baseline, 3 and 6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in New York Heart Association Functional Classification assessment</measure>
    <time_frame>baseline, 3 and 6 months</time_frame>
    <description>Changes in New York Heart Association Functional Classification</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Echocardiography: bi ventricular function (2D and 3D)</measure>
    <time_frame>baseline, 3 and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Echocardiography: assessment of left atrium (2D and 3D)</measure>
    <time_frame>baseline, 3 and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Echocardiography: assessment of heart valves</measure>
    <time_frame>baseline, 3 and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Echocardiography: strain using speckle tracking</measure>
    <time_frame>baseline, 3 and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Echocardiography: evaluation of iatrogenic ASD (2D and 3D)</measure>
    <time_frame>baseline, 3 and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart insufficiency bio markers</measure>
    <time_frame>baseline and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Cardiac MRI: bi ventricular function</measure>
    <time_frame>baseline and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Cardiac MRI: left ventricular longitudinal strain</measure>
    <time_frame>baseline and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Cardiac MRI: left ventricular circumferential strain</measure>
    <time_frame>baseline and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Cardiac MRI: flow measurements in main pulmonary artery and aorta</measure>
    <time_frame>baseline and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of hospitalisation rate</measure>
    <time_frame>baseline, 3, 6 and 12 months</time_frame>
    <description>Telephone</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of mortality</measure>
    <time_frame>baseline, 3, 6 and 12 months</time_frame>
    <description>Telephone</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Combined endpoint (hospitalisation and mortality)</measure>
    <time_frame>baseline, 3, 6 and 12 months</time_frame>
    <description>Telephone; Combined Endpoint of hospitalisation and mortality. For analysis the first event is counted regardless of severity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in quality of life in &quot;Minnesota Living with Heart Failure&quot; questionnaire</measure>
    <time_frame>baseline and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in quality of life in &quot;Short Form - 36&quot; questionnaire</measure>
    <time_frame>baseline and 6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Mitral Valve Insufficiency</condition>
  <condition>Heart Septal Defects, Atrial</condition>
  <arm_group>
    <arm_group_label>A: interventional closure of iASD</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Interventional closure of iASD (n=40) with an Figulla Flex Occluder (Occlutech)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B: no intervention</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Best medical supportive care (n=40)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Figulla Flex Occluder (Occlutech)</intervention_name>
    <description>Interventional closure of the iASD with an Figulla Flex Occluder (Occlutech)</description>
    <arm_group_label>A: interventional closure of iASD</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Informed consent

          -  Previous MitraClip implantation

          -  Persistent relevant iASD 30 days after MitraClip intervention

        Exclusion Criteria:

          -  Unsuccessful MitraClip implantation

          -  No relevant iASD 30 days after MitraClip intervention

          -  Unstable angina in the previous 4 weeks

          -  Valvular heart disease (aortic, tricuspid or pulmonary valve) planed for surgery or
             interventional therapy

          -  Constrictive pericarditis / restrictive cardiomyopathies

          -  Pericardial effusion planed for surgery or interventional therapy

          -  Coagulation disorders

          -  Malignant disease with a life expectance &lt; 12 months

          -  Pregnancy

          -  Participation in another study

          -  iASD diameter &gt; 38 mm

          -  Aortic minimum distance of the iASD &lt; 5 mm

          -  Thrombus in left atrial appendage

          -  Venous access impossible with a 24 French catheter system

          -  Presence of an inferior vena cava filter
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philipp Lurz, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Heart Center of the University Leipzig</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stephan Blazek, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Heart Center of the University Leipzig</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Philipp Lurz, MD, PhD</last_name>
    <phone>+49341865252022</phone>
    <email>Philipp.Lurz@gmx.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Stephan Blazek, MD</last_name>
    <phone>+49341865252025</phone>
    <email>stephan.blazek@medizin.uni-leipzig.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Heart Center of the University Leipzig</name>
      <address>
        <city>Leipzig</city>
        <zip>04289</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philipp Lurz, MD, PhD</last_name>
      <phone>+49341865252022</phone>
      <email>Philipp.Lurz@gmx.de</email>
    </contact>
    <investigator>
      <last_name>Philipp Lurz, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 29, 2016</study_first_submitted>
  <study_first_submitted_qc>January 13, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 18, 2017</study_first_posted>
  <last_update_submitted>February 1, 2018</last_update_submitted>
  <last_update_submitted_qc>February 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Leipzig</investigator_affiliation>
    <investigator_full_name>Philipp Lurz</investigator_full_name>
    <investigator_title>Clinical Investigator M.D. Ph. D. Philipp Lurz</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Septal Defects</mesh_term>
    <mesh_term>Mitral Valve Insufficiency</mesh_term>
    <mesh_term>Heart Septal Defects, Atrial</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

